Will stars align again for biotech backer?
Constellation will tap DNA research to create drugs
Millennium Pharmaceuticals Inc. cofounder Mark Levin has long been a key figure in the region's biotech industry. Known for his colorful shirts and even bolder statements, Levin, 57, once predicted Millennium would become a $100 billion company and revolutionize the way drugs work by unraveling the body's genetic code. Though the Cambridge biotech has yet to fulfill that promise, Levin ... (Full article: 1060 words)
This article is available in our archives:
Globe Subscribers
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly





